Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Over the past decade, messenger RNA (mRNA) has emerged as potent and flexible platform for the development of novel effective cancer immunotherapies. Advances in non-viral gene delivery technologies, especially the tremendous progress in lipid nanoparticles' manufacturing, have made possible th...

Descripción completa

Detalles Bibliográficos
Autores principales: Guevara, Maria L., Persano, Francesca, Persano, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645050/
https://www.ncbi.nlm.nih.gov/pubmed/33195094
http://dx.doi.org/10.3389/fchem.2020.589959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645050/
https://www.ncbi.nlm.nih.gov/pubmed/33195094
http://dx.doi.org/10.3389/fchem.2020.589959

Ejemplares similares